Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19

ABSTRACTAlthough severe coronavirus disease 2019 (COVID-19) and hospitalization associated with COVID-19 are generally preventable among healthy vaccine recipients, patients with immunosuppression have poor immunogenic responses to COVID-19 vaccines and remain at high risk of infection with SARS-CoV...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Juan G. Ripoll, Sidna M. Tulledge-Scheitel, Anthony A. Stephenson, Shane Ford, Marsha L. Pike, Ellen K. Gorman, Sara N. Hanson, Justin E. Juskewitch, Alex J. Miller, Solomiia Zaremba, Erik A. Ovrom, Raymund R. Razonable, Ravindra Ganesh, Ryan T. Hurt, Erin N. Fischer, Amber N. Derr, Michele R. Eberle, Jennifer J. Larsen, Christina M. Carney, Elitza S. Theel, Sameer A. Parikh, Neil E. Kay, Michael J. Joyner, Jonathon W. Senefeld
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology 2024-05-01
Colecção:	mBio
Assuntos:	antibody therapy SARS-CoV-2 immunocompromised hosts
Acesso em linha:	https://journals.asm.org/doi/10.1128/mbio.00400-24
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!